PROTAB LTD has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CAMBRIDGE ANTIBODY TECH, PIERIS PROTEOLAB AG and AMUNIX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | United States | 2 | |
#7 | Brazil | 1 | |
#8 | India | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Naparstek Yaakov | 17 |
#2 | Yair Shira | 12 |
#3 | Yaakov Naparstek | 3 |
#4 | Moallem Eli | 3 |
#5 | Hershko Alon | 2 |
#6 | Eli Moallem | 2 |
#7 | Landstein Dorit | 2 |
#8 | Shira Yair | 1 |
Publication | Filing date | Title |
---|---|---|
EP2475383A1 | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof | |
CN102448990A | Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation | |
EP2215230A2 | Regulatory sequences derived from il-10 promoter and uses thereof in modulation of immune response |